Search - tctmd.com

Displaying 1 - 10 of 10

Sort: Relevancy | Date

News Opinion Editor's Corner AHA 2025

What’s Going to Be Hot at AHA 2025?

Michael O'Riordan

November 05, 2025

News Conference News AHA 2023

Placebo-Controlled ORBITA-2 Shows PCI Eases Symptoms in Stable Angina

Michael O'Riordan

November 11, 2023

News Conference News AHA 2022

SPYRAL HTN-ON MED Trial of Renal Denervation Misses Primary Endpoint

Todd Neale

November 09, 2022

Presentation AHA 2022

Renal Denervation in the Presence of Anti-Hypertensive Medications: Six-Month Results from the Randomized, Blinded, Sham-Controlled SPYRAL HTN – ON MED Trial

Presenter: David E. Kandzari

November 07, 2022

News Conference News AHA 2017

Circling Back on ORBITA: Sham-Controlled PCI Trial Makes Best of 2017 List

Michael O'Riordan

November 12, 2017

News Conference News AHA 2013

AHA 2013: Mix of Positive, Negative Trials Help Guide Interventional Practice

November 24, 2013

News Conference News AHA 2013

RADAR-AF: HF Source Ablation Does Not Benefit Paroxysmal, Persistent A-fib Patients

Yael L. Maxwell

November 19, 2013

News Conference News AHA 2013

Long-term Outcomes with Renal Denervation Show Sustained Benefit

Yael L. Maxwell

November 16, 2013

News Conference News AHA 2012

AHA 2012: Multiple Studies Provide Clinical Guidance for Interventional Community

Jason Kahn

November 11, 2012

News Conference News AHA 2012

Early Study Shows Positive Clinical Results with Novel Renal Denervation Device

Jason Kahn

November 04, 2012

Advertisement

What’s Going to Be Hot at AHA 2025?

Placebo-Controlled ORBITA-2 Shows PCI Eases Symptoms in Stable Angina

SPYRAL HTN-ON MED Trial of Renal Denervation Misses Primary Endpoint

Renal Denervation in the Presence of Anti-Hypertensive Medications: Six-Month Results from the Randomized, Blinded, Sham-Controlled SPYRAL HTN – ON MED Trial

Circling Back on ORBITA: Sham-Controlled PCI Trial Makes Best of 2017 List

AHA 2013: Mix of Positive, Negative Trials Help Guide Interventional Practice

RADAR-AF: HF Source Ablation Does Not Benefit Paroxysmal, Persistent A-fib Patients

Long-term Outcomes with Renal Denervation Show Sustained Benefit

AHA 2012: Multiple Studies Provide Clinical Guidance for Interventional Community

Early Study Shows Positive Clinical Results with Novel Renal Denervation Device

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content